-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Funobactam in Ventilator Associated Pneumonia (VAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Funobactam in Ventilator Associated Pneumonia (VAP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Funobactam in Ventilator Associated Pneumonia (VAP) Drug Details: XNW-4107 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamitresgene Autoleucel in Gastric Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Afamitresgene Autoleucel in Gastric Cancer Drug Details: ADPA-2M4 is under development for the treatment of...
-
Product Insights
NewNon-Rhabdomyosarcoma – Drugs In Development, 2024
Empower your strategies with our Non-Rhabdomyosarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Non-rhabdomyosarcoma refers to a group of cancers that are distinct from rhabdomyosarcoma, a type of soft tissue cancer that arises from skeletal muscle cells. Non-rhabdomyosarcoma includes various types of soft tissue sarcomas that originate in tissues such as nerves, blood vessels, fat, and connective tissues. These sarcomas can occur in different parts of the body, and their characteristics and treatment approaches vary. Common...
-
Product Insights
NewSynovial Sarcoma – Drugs In Development, 2024
Empower your strategies with our Synovial Sarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, mass that may or may not be accompanied by pain and limping or difficulty using legs, arms, hands or feet. Treatment includes surgery, radiation therapy and chemotherapy. The Synovial Sarcoma drugs in development market research report provide...
-
Product Insights
NewPeripheral Nerve Sheath Tumor (Neurofibrosarcoma) – Drugs In Development, 2024
Empower your strategies with our Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) – Drugs In Development, 2024 report and make more profitable business decisions. Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas that originate from peripheral nerves or from cells associated with the nerve sheath, such as Schwann cells, perineural cells, or fibroblasts. Symptoms include a lump or swelling in the in the soft tissue, numbness, burning, tingling or pins and needles, weakness of the affected muscles, and dizziness or loss of balance....
-
Product Insights
NewSquamous Non-Small Cell Lung Cancer – Drugs In Development, 2024
Empower your strategies with our Squamous Non-Small Cell Lung Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Squamous cell carcinoma is a subtype of non-small cell lung cancer (NSCLC) originating in the squamous cells lining the airways. It constitutes about 25-30% of all lung cancers. Linked to smoking, symptoms include persistent cough, chest pain, and breathing difficulties. Diagnosis involves imaging, biopsy, and staging to determine the cancer's extent. Treatment options depend on the stage but may...
-
Product Insights
NewEsophageal Squamous Cell Carcinoma (ESCC) – Drugs In Development, 2024
Empower your strategies with our Esophageal Squamous Cell Carcinoma (ESCC) – Drugs In Development, 2024 report and make more profitable business decisions. Esophageal squamous cell carcinoma (ESCC) is a type of cancer that arises from the squamous cells lining the esophagus, the muscular tube connecting the throat to the stomach. Commonly associated with tobacco and alcohol use, as well as dietary factors, ESCC is prevalent in certain geographic regions. Symptoms often manifest late and include difficulty swallowing, weight loss, and chest...
-
Product Insights
NewMyxoid Liposarcoma – Drugs In Development, 2024
Empower your strategies with our Myxoid Liposarcoma – Drugs In Development, 2024 report and make more profitable business decisions. A myxoid liposarcoma is a malignant adipose tissue neoplasm of myxoid appearance histologically. Myxoid/round cell liposarcoma, or MRCLS, is one of several types of liposarcoma. Liposarcoma is a rare cancer that grows in the cells that store fat in the body. MRCLS usually grows in the arms and legs. These tumors grow slowly, and they can spread to other parts of the...
-
Product Insights
NewRound Cell Liposarcoma – Drugs In Development, 2024
Empower your strategies with our Round Cell Liposarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Round cell liposarcoma, also called myxoid or MRCLS, is one of several types of liposarcoma. Liposarcoma is a rare cancer that grows in the cells that store fat in the body. MRCLS tumors usually grow in the arms and legs. These tumors grow slowly, and they can spread to other parts of the body. The Round Cell Liposarcoma drugs in development...